Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A O'Callaghan

Showing results (121-130 of 186) with videos related to

Pageof 19
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2002
Cutting edge: the minor histocompatibility antigen H60 peptide interacts with both H-2Kb and NKG2DAdelheid Cerwenka, Christopher A O'Callaghan, Jessica A Hamerman, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 1, 1994
Acute arsenic poisoning: absence of polyneuropathy after treatment with 2,3-dimercaptopropanesulphonate (DMPS)D F Moore, C A O'Callaghan, G Berlyne, et al.
Analytical Biochemistry|January 15, 1999
BirA enzyme: production and application in the study of membrane receptor-ligand interactions by site-specific biotinylationC A O'callaghan, M F Byford, J R Wyer, et al.
European Journal of Immunology|June 1, 1997
Combined structural and immunological refinement of HIV-1 HLA-B8-restricted cytotoxic T lymphocyte epitopesP J Goulder, S W Reid, D A Price, et al.
Heart (British Cardiac Society)|July 17, 2001
Symptomatic improvement after radiofrequency catheter ablation for typical atrial flutterP A O'Callaghan, M Meara, E Kongsgaard, et al.
Plos One|January 15, 2021
Prevalence and factors associated with multimorbidity among primary care patients with decreased renal functionJennifer A Hirst, José M Ordóñez Mena, Chris A O'Callaghan, et al.
Plos One|July 8, 2016
Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-AnalysisNathan R Hill, Samuel T Fatoba, Jason L Oke, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|December 2, 2005
New and old cardiovascular risk factors: C-reactive protein, homocysteine, cysteine and von Willebrand factor increase risk, especially in smokersPatrick A O'Callaghan, Anthony Fitzgerald, Jane Fogarty, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 8, 1998
Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I moleculesM Colonna, J Samaridis, M Cella, et al.
Microorganisms|July 27, 2022
<i>Lactobacillus salivarius</i> UCC118™ Dampens Inflammation and Promotes Microbiota Recovery to Provide Therapeutic Benefit in a DSS-Induced Colitis ModelNamrata Iyer, Michelle A Williams, Amy A O'Callaghan, et al.
Pageof 19

Showing results (121-130 of 186) with videos related to

Sort By:
Pageof 19
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2002
Cutting edge: the minor histocompatibility antigen H60 peptide interacts with both H-2Kb and NKG2DAdelheid Cerwenka, Christopher A O'Callaghan, Jessica A Hamerman, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 1, 1994
Acute arsenic poisoning: absence of polyneuropathy after treatment with 2,3-dimercaptopropanesulphonate (DMPS)D F Moore, C A O'Callaghan, G Berlyne, et al.
Analytical Biochemistry|January 15, 1999
BirA enzyme: production and application in the study of membrane receptor-ligand interactions by site-specific biotinylationC A O'callaghan, M F Byford, J R Wyer, et al.
European Journal of Immunology|June 1, 1997
Combined structural and immunological refinement of HIV-1 HLA-B8-restricted cytotoxic T lymphocyte epitopesP J Goulder, S W Reid, D A Price, et al.
Heart (British Cardiac Society)|July 17, 2001
Symptomatic improvement after radiofrequency catheter ablation for typical atrial flutterP A O'Callaghan, M Meara, E Kongsgaard, et al.
Plos One|January 15, 2021
Prevalence and factors associated with multimorbidity among primary care patients with decreased renal functionJennifer A Hirst, José M Ordóñez Mena, Chris A O'Callaghan, et al.
Plos One|July 8, 2016
Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-AnalysisNathan R Hill, Samuel T Fatoba, Jason L Oke, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|December 2, 2005
New and old cardiovascular risk factors: C-reactive protein, homocysteine, cysteine and von Willebrand factor increase risk, especially in smokersPatrick A O'Callaghan, Anthony Fitzgerald, Jane Fogarty, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 8, 1998
Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I moleculesM Colonna, J Samaridis, M Cella, et al.
Microorganisms|July 27, 2022
<i>Lactobacillus salivarius</i> UCC118™ Dampens Inflammation and Promotes Microbiota Recovery to Provide Therapeutic Benefit in a DSS-Induced Colitis ModelNamrata Iyer, Michelle A Williams, Amy A O'Callaghan, et al.
Pageof 19